CBD is not generally considered safe for children outside of one specific medical use: treating certain severe seizure disorders under a doctor’s supervision. The FDA has approved a single prescription CBD medication for children as young as 1 year old, but no over-the-counter CBD product has been approved for any pediatric use. The American Academy of Pediatrics warns that cannabis-based products, including CBD, can be toxic to young children.
The One FDA-Approved Use for Kids
Epidiolex is a purified, pharmaceutical-grade CBD oral solution and the only CBD product the FDA has approved for children. It’s prescribed for seizures associated with three conditions: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. Children as young as 1 year old can receive it, and dosing is carefully calculated by weight, starting low and increasing over weeks based on how the child responds.
This is a prescription medication monitored with regular blood work, not something parents pick up at a health food store. The distinction matters because the safety profile of pharmaceutical CBD, manufactured under strict quality controls, is very different from what you’d find on a store shelf.
Why Over-the-Counter CBD Is Risky for Children
The biggest problem with retail CBD products is that what’s on the label often has little to do with what’s in the bottle. A UK analysis found only 38% of CBD products contained CBD within 10% of the advertised amount. The average deviation from the labeled dose was 76%. A similar U.S. study of 84 products found only 31% were accurately labeled. Studies in the Netherlands and Italy reported similar results.
Even more concerning for children: 55% of UK products tested contained detectable levels of THC, the compound in cannabis that produces a high. In the U.S. study, THC was found in 18 of the 84 products, sometimes above regulated limits. For a small child, even trace amounts of THC could cause real problems. The AAP notes that cannabis product toxicity in young children can cause extreme confusion, anxiety, paranoia, fast heart rate, hallucinations, increased blood pressure, and severe nausea or vomiting.
Without FDA regulation of these products, there’s no reliable way to verify purity, potency, or the absence of contaminants like heavy metals or pesticides. A certificate of analysis from a third-party lab helps, but it’s not a guarantee, and most parents aren’t equipped to interpret one.
How Children Process CBD Differently
Children don’t metabolize CBD the same way adults do. Pharmacokinetic modeling shows that children clear CBD from their bloodstream at roughly 63% the rate of adults. That means CBD lingers longer in a child’s system, potentially amplifying both its effects and its side effects. While the overall accumulation in the body ends up comparable to adults at adjusted doses, getting the dose right is more critical and more difficult without medical oversight.
CBD also interacts with a long list of other medications. It can raise blood levels of common seizure drugs, immune-suppressing medications, and other prescriptions a child might be taking. For clobazam, a seizure medication frequently used alongside Epidiolex, CBD increases levels of one of its breakdown products, which has been linked to increased drowsiness and sedation. This is one reason children on Epidiolex require ongoing lab monitoring.
Side Effects in Clinical Settings
Even under medical supervision with pharmaceutical-grade CBD, side effects are common. In a 48-week clinical trial, 97% of participants reported some adverse effects. The most frequent were diarrhea (63%), headache (50%), abdominal pain (47%), nausea (43%), and fatigue (33%). More than 10% experienced dizziness, drowsiness, or skin rash.
The liver concern is particularly important. About 10% of patients in the trial showed elevated liver enzymes at levels three times the upper limit of normal, a sign of liver stress. Children taking other medications that affect the liver are at higher risk. This is why doctors order liver function tests before and during treatment with Epidiolex.
What About CBD for ADHD or Anxiety?
Many parents searching this question are wondering about CBD for behavioral or mental health conditions. The evidence here is thin. One small open-label study found that CBD-rich cannabis oil improved hyperactivity, attention, and anxiety scores in children with autism spectrum disorder. But open-label studies lack a placebo group, so it’s impossible to separate the effect of CBD from the effect of parents and children expecting improvement. No controlled clinical trial has established CBD as effective for pediatric ADHD or anxiety.
Meanwhile, the developing brain is particularly sensitive to anything that interacts with the body’s endocannabinoid system, which plays a central role in how reward and stress pathways mature during childhood and adolescence. CBD does interact with cannabinoid receptors, though its mechanism isn’t fully understood and research findings are inconsistent. The potential for disrupting normal brain development during these critical years hasn’t been ruled out.
The Bottom Line on CBD and Kids
Prescription CBD under medical supervision has a legitimate role in treating severe childhood seizure disorders. Outside of that narrow use, giving CBD to a child means giving them an unregulated substance with unpredictable potency, possible THC contamination, known side effects including liver stress, and unknown long-term effects on brain development. The American Academy of Pediatrics has not endorsed any non-prescription CBD use in children, and the FDA has not approved any over-the-counter CBD product for diagnosing, treating, or preventing any disease in any age group.